Abhinav Shukla
Directeur Technique/Scientifique/R&D chez SHATTUCK LABS, INC.
Fortune : 586 171 $ au 31/05/2024
Provenance du réseau au premier degré de Abhinav Shukla
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
| Public Company | Biotechnology | 6 | |
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Abhinav Shukla via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | General Counsel Chief Investment Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SCORPIUS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Villanova University | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
| Rochester Christian University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Investment Managers | Founder Private Equity Investor | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Hospital/Nursing Management | Founder Director/Board Member | |
| The University of Texas at Austin | College/University | Undergraduate Degree Doctorate Degree | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing | |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree | |
Vascular Flow Technologies Ltd.
 Vascular Flow Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vascular Flow Technologies Ltd. develops vascular devices. It offers Spiral Flow Peripheral Vascular Graft, Spiral Flow AV Access Graft, Spiral Laminar Flow, Power of Spiral Laminar Flow and unique design eliminates graft turbulences. The company was founded by Peter Stonebridge, Brian Howlett, Graeme Houston and John B.C. Dick and headquartered in Dundee, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
| YUM! BRANDS, INC. | Restaurants | Corporate Officer/Principal | |
| PREMIER, INC. | Hospital/Nursing Management | Director/Board Member | |
Field Trip Health, Inc.
 Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Director/Board Member | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| EVAXION BIOTECH A/S | Biotechnology | Director/Board Member | |
Bill & Melinda Gates Medical Research Institute
 Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization based in Cambridge, MA. The institute focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). Bill & Melinda Gates Medical Research Institute works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. Patrice Matchaba has been the CEO of the company since 2024. | Miscellaneous Commercial Services | Chief Operating Officer | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Field Trip Psychedelics, Inc.
 Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Director/Board Member | |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | Medical Distributors | Corporate Officer/Principal | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
| Estuary Ventures LLC | Chief Executive Officer | ||
Image Analysis Ltd.
 Image Analysis Ltd. Internet Software/ServicesTechnology Services Image Analysis Ltd. operates as an imaging clinical research organization. It supports optimal design and data management of clinical trials. The company was founded by Olga Kubassova in 2007 and is headquartered in London, the United Kingdom. | Internet Software/Services | Director/Board Member | |
| IMMUNOGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Denison University | College/University | Undergraduate Degree | |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
| CARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Enso Ventures Ltd.
 Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
HSBC Investment Bank Plc
 HSBC Investment Bank Plc Regional BanksFinance Part of HSBC Holdings Plc, HSBC Investment Bank Plc provides stock broking services. The company is based in London, UK. | Regional Banks | Corporate Officer/Principal | |
NATRIX Separations, Inc.
 NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Medical Specialties | Corporate Officer/Principal | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Ascend Gene & Cell Therapies Ltd.
 Ascend Gene & Cell Therapies Ltd. Miscellaneous Commercial ServicesCommercial Services Ascend Gene & Cell Therapies Ltd. is a gene and cell therapy manufacturing specialist that aims to create effective gene therapies to a world-class standard. The company is based in Altrincham, UK, and has subsidiaries in Germany. The British company focuses on constantly refining and flexing their approach and embracing opportunities to innovate to create therapies that change lives. Ascend has over $130m of funding as expert teams merge. The company has a solid platform that allows their team to do their best work and deliver unwavering quality. Timothy Michael Funnell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Hamburg | College/University | Undergraduate Degree | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
| State University of St. Petersburg | College/University | Undergraduate Degree | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| University of Massachusetts | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 35 |
| Royaume-Uni | 9 |
| Canada | 6 |
| Danemark | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 14 |
| Health Services | 6 |
| Commercial Services | 5 |
| Finance | 4 |
Opérationnelle
| Director/Board Member | 121 |
| Corporate Officer/Principal | 87 |
| Independent Dir/Board Member | 42 |
| Chief Tech/Sci/R&D Officer | 34 |
| Undergraduate Degree | 30 |
Relations les plus connectées
| Insiders | |
|---|---|
| Thomas Woiwode | 39 |
| George Golumbeski | 36 |
| Kurt von Emster | 34 |
| Helen Boudreau | 22 |
| Neil Gibson | 20 |
| George Elston | 18 |
| Brian McVeigh | 15 |
| Stephen Kennedy | 13 |
| James G. Stout | 13 |
| Andrey Kozlov | 12 |
| Katherine High | 12 |
| Josiah Hornblower | 11 |
| James Chopas | 10 |
| John Greene | 10 |
| Casi de Young | 10 |
- Bourse
- Insiders
- Abhinav Shukla
- Connexions Sociétés
